Public Employees Retirement Association of Colorado’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | $1.07M | Sell |  | |||||
| 2025 Q1 | $1.4M | Hold |  | |||||
| 2024 Q4 | $1.3M | Hold |  | |||||
| 2024 Q3 | $1.39M | Hold |  | |||||
| 2024 Q2 | $1.63M | Sell |  | |||||
| 2024 Q1 | $1.84M | Sell |  | |||||
| 2023 Q4 | $2.12M | Sell |  | |||||
| 2023 Q3 | $2.04M | Sell |  | |||||
| 2023 Q2 | $2.06M | Hold |  | |||||
| 2023 Q1 | $2.31M | Hold |  | |||||
| 2022 Q4 | $2.46M | Hold |  | |||||
| 2022 Q3 | $2.01M | Hold |  | |||||
| 2022 Q2 | $1.97M | Hold |  | |||||
| 2022 Q1 | $1.83M | Sell |  | |||||
| 2021 Q4 | $2.31M | Hold |  | |||||
| 2021 Q3 | $2.02M | Hold |  | |||||
| 2021 Q2 | $2.19M | Hold |  | |||||
| 2021 Q1 | $1.98M | Hold |  | |||||
| 2020 Q4 | $2.3M | Sell |  | |||||
| 2020 Q3 | $17M | Sell |  | |||||
| 2020 Q2 | $28M | Buy |  | |||||
| 2020 Q1 | $17.5M | Buy |  | |||||
| 2019 Q4 | $17.5M | Buy |  | |||||
| 2019 Q3 | $13.1M | Buy |  | |||||
| 2019 Q2 | $11M | Buy |  | |||||
| 2019 Q1 | $2.33M | Sell |  | |||||
| 2018 Q4 | $2.78M | Sell |  | |||||
| 2018 Q3 | $3.18M | Sell |  | |||||
| 2018 Q2 | $3.09M | Sell |  | |||||
| 2018 Q1 | $2.66M | Sell |  | |||||
| 2017 Q4 | $3.05M | Buy |  | |||||
| 2017 Q3 | $3.08M | Sell |  | |||||
| 2017 Q2 | $3.07M | Buy |  | |||||
| 2017 Q1 | $2.96M | Sell |  | |||||
| 2016 Q4 | $2.8M | Sell |  | |||||
| 2016 Q3 | $3.13M | Sell |  | |||||
| 2016 Q2 | $2.72M | Sell |  | |||||
| 2016 Q1 | $2.97M | Sell |  | |||||
| 2015 Q4 | $3.96M | Buy |  | |||||
| 2015 Q3 | $3.97M | Sell |  | |||||
| 2015 Q2 | $5.17M | Sell |  | |||||
| 2015 Q1 | $5.04M | Sell |  | |||||
| 2014 Q4 | $9.59M | Sell |  | |||||
| 2014 Q3 | $7.66M | Sell |  | |||||
| 2014 Q2 | $6.61M | Sell |  | |||||
| 2014 Q1 | $10.6M | Sell |  | |||||
| 2013 Q4 | $11M | Buy |  | |||||
| 2013 Q3 | $11.3M | Buy |  | |||||
| 2013 Q2 | $8.68M | Buy |  |